Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4722
Source ID: NCT02401243
Associated Drug: Insulin Glargine (U300)
Title: Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients
Acronym: TITRATION
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: INSULIN GLARGINE (U300)
Outcome Measures: Primary: Percentage of patients reaching fasting SMPG ≤5.6 mmol/L without nocturnal (midnight to 6:00 am) hypoglycemia (confirmed or symptomatic or severe), 12 weeks | Secondary: Percentage of patients with adverse events, 12 weeks
Sponsor/Collaborators: Sponsor: Sanofi
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 253
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2015-03
Completion Date: 2016-02
Results First Posted:
Last Update Posted: 2016-03-28
Locations: Investigational Site Number 124001, Abbotsford, V2S3N5, Canada|Investigational Site Number 124013, Brampton, L6T4V3, Canada|Investigational Site Number 124008, Burlington, Canada|Investigational Site Number 124024, Burnaby, V5G1T4, Canada|Investigational Site Number 124015, Collingwood, L9Y1W3, Canada|Investigational Site Number 124025, Corunna, N0N 1G0, Canada|Investigational Site Number 124019, Etobicoke, M9V4V4, Canada|Investigational Site Number 124021, Hamilton, Canada|Investigational Site Number 124011, Laval, H7T 2P5, Canada|Investigational Site Number 124005, Levis, G6W5M6, Canada|Investigational Site Number 124018, London, N5W 6A2, Canada|Investigational Site Number 124003, Oshawa, Canada|Investigational Site Number 124010, Quebec, G1W4R4, Canada|Investigational Site Number 124012, Quebec, Canada|Investigational Site Number 124007, Sarnia, N7T 4R9, Canada|Investigational Site Number 124002, Saskatoon, S7K 3H3, Canada|Investigational Site Number 124023, Sherbrooke, J1G5K2, Canada|Investigational Site Number 124009, Smiths Falls, K7A4W8, Canada|Investigational Site Number 124017, Strathroy, N7G1Y7, Canada|Investigational Site Number 124020, Toronto,, M8V3X8, Canada|Investigational Site Number 124006, Vancouver, V5Z1M9, Canada|Investigational Site Number 124026, Vancouver, V6J1S3, Canada|Investigational Site Number 124004, Victoria, V8V4H1, Canada|Investigational Site Number 124014, Winnipeg, R2V4W3, Canada|Investigational Site Number 124016, Winnipeg, R3E 3P4, Canada
URL: https://clinicaltrials.gov/show/NCT02401243

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress